FHTX vs UDR · rev $19.3M vs P/E 26, rev $1.71B
Foghorn Therapeutics Inc (FHTX) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
Latest reported UDR revenue for 2025-12-31 was $1.71B. Net income was $377.7M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
FHTX currently screens at market cap $237.8M. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the FHTX and UDR stock pages for the full models.
Not investment advice.